Rapp–Hodgkin syndrome

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Rapp–Hodgkin syndrome
Synonyms Rapp–Hodgkin ectodermal dysplasia
Pronounce
Specialty Medical genetics
Symptoms Cleft lip and palate, hypohidrosis, sparse hair, dental anomalies
Complications N/A
Onset
Duration
Types
Causes Mutations in the TP63 gene
Risks
Diagnosis Clinical examination, genetic testing
Differential diagnosis Ectodermal dysplasia, Hay–Wells syndrome
Prevention
Treatment Symptomatic treatment, dental care, speech therapy
Medication
Prognosis
Frequency Rare
Deaths


Rapp–Hodgkin syndrome (RHS) is a rare genetic disorder characterized by a combination of ectodermal dysplasia, cleft lip and palate, and other anomalies. It is named after the researchers Robert S. Rapp and Peter J. Hodgkin, who first described the syndrome.

Presentation[edit]

Individuals with Rapp–Hodgkin syndrome typically present with a variety of symptoms, including:

Genetics[edit]

Rapp–Hodgkin syndrome is inherited in an autosomal dominant manner. Mutations in the TP63 gene, which plays a crucial role in the development of ectodermal tissues, are responsible for the condition. The TP63 gene is also implicated in other syndromes such as Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome (EEC) and Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate syndrome (AEC).

Diagnosis[edit]

Diagnosis of Rapp–Hodgkin syndrome is based on clinical evaluation and the identification of characteristic features. Genetic testing can confirm the presence of mutations in the TP63 gene. Differential diagnosis includes other forms of ectodermal dysplasia and syndromes with overlapping features.

Management[edit]

Management of Rapp–Hodgkin syndrome is symptomatic and supportive. This may include:

Epidemiology[edit]

Rapp–Hodgkin syndrome is extremely rare, with only a few cases reported in the medical literature. The exact prevalence is unknown.

See also[edit]

References[edit]

External links[edit]

-


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.